DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

Issue 07 · Volume 119 · July 2019 DOI: 10.1055/s-009-43375

Invited Editorial Focus

  • 1031
  • 1033
  • Invited T&H Insights

  • 1036
  • Review Article

  • 1037
  • Coagulation and Fibrinolysis

  • 1048
  • 1058
  • 1072
  • 1084
  • 1094
    Engelberger, Rolf P.; Schroeder, Verena; Nagler, Michael; Prince, Raja; Périard, Daniel; Hayoz, Daniel; Kucher, Nils:

    Enhanced Thrombolysis by Ultrasound-Assisted Catheter-Directed Thrombolysis and Microbubbles in an In Vitro Model of Iliofemoral Deep Vein Thrombosis

  • Cellular Haemostasis and Platelets

  • 1102
  • 1112
    Hamadi, Abdullah; Grigg, Andrew P.; Dobie, Gasim; Burbury, Kate L.; Schwarer, Anthony P.; Kwa, Faith A.; Jackson, Denise E.:

    Ponatinib Tyrosine Kinase Inhibitor Induces a Thromboinflammatory Response

  • 1124
    Clark, Joanne C.; Kavanagh, Deirdre M.; Watson, Stephanie; Pike, Jeremy A.; Andrews, Robert K.; Gardiner, Elizabeth E.; Poulter, Natalie S.; Hill, Stephen J.; Watson, Steve P.:

    Adenosine and Forskolin Inhibit Platelet Aggregation by Collagen but not the Proximal Signalling Events

  • 1138
    Vayne, Caroline; May, Marc-Antoine; Bourguignon, Thierry; Lemoine, Eric; Guery, Eve-Anne; Rollin, Jérôme; Gruel, Yves; Pouplard, Claire:

    Frequency and Clinical Impact of Platelet Factor 4-Specific Antibodies in Patients Undergoing Extracorporeal Membrane Oxygenation

  • Blood Cells, Inflammation and Infection

  • 1147
    Hollerbach, Anne; Müller-Calleja, Nadine; Ritter, Svenja; Häuser, Friederike; Canisius, Antje; Orning, Carolin; Jurk, Kerstin; Lackner, Karl J.:

    Platelet Activation by Antiphospholipid Antibodies Depends on Epitope Specificity and is Prevented by mTOR Inhibitors

  • New Technologies, Diagnostic Tools and Drugs

  • 1154
    Althaus, Karina; Zieger, Barbara; Bakchoul, Tamam; Jurk, Kerstin; On behalf of THROMKID-Plus Studiengruppe der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) und der Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH):

    Standardization of Light Transmission Aggregometry for Diagnosis of Platelet Disorders: An Inter-Laboratory External Quality Assessment

  • Stroke, Systemic or Venous Thromboembolism

  • 1162
    Chao, Tze-Fan; Liao, Jo-Nan; Tuan, Ta-Chuan; Lin, Yenn-Jiang; Chang, Shih-Lin; Lo, Li-Wei; Hu, Yu-Feng; Chung, Fa-Po; Chen, Tzeng-Ji; Lip, Gregory Y. H.; Chen, Shih-Ann:

    Incident Co-Morbidities in Patients with Atrial Fibrillation Initially with a CHA2DS2-VASc Score of 0 (Males) or 1 (Females): Implications for Reassessment of Stroke Risk in Initially ‘Low-Risk’ Patients

  • Atherosclerosis and Ischaemic Disease

  • 1171
    Ubaid, Salahaddin; Ford, Thomas J.; Berry, Colin; Murray, Heather M.; Wrigley, Benjamin; Khan, Nazish; Thomas, Mark R.; Armesilla, Angel L.; Townend, Jon N.; Khogali, Saib S.; Munir, Shahzad; Martins, Joe; Hothi, Sandeep S.; McAlindon, Elisa J.; Cotton, James M.:

    Cangrelor versus Ticagrelor in Patients Treated with Primary Percutaneous Coronary Intervention: Impact on Platelet Activity, Myocardial Microvascular Function and Infarct Size: A Randomized Controlled Trial

  • 1182
    Kang, Jeehoon; Park, Kyung Woo; Ki, You-Jeong; Park, Jiesuck; Rhee, Taemin; Kim, Chee-Hoon; Han, Jung-Kyu; Yang, Han-Mo; Kang, Hyun-Jae; Koo, Bon-Kwon; Nakamura, Masato; Hamasaki, Toshimitsu; Yokoi, Hiroyoshi; Cohen, David; Kim, Hyo-Soo:

    Development and Validation of an Ischemic and Bleeding Risk Evaluation Tool in East Asian Patients Receiving Percutaneous Coronary Intervention

  • Letter to the Editor

  • 1194